Get started
Author

Ashtyn McAdoo

Observed names: A. McAdoo, Ashtyn G McAdoo, Ashtyn G. McAdoo
OpenAlex ID: A5093963776
Programmed cell death protein 1 (PD-1) blockade regulates skeletal remodeling in a sex- and age-dependent manner
2025 · Gwenyth J Joseph, Lawrence A Vecchi III, et al. · Journal of Bone and Mineral Research · 12
Circulating Tumor Tissue‐Modified‐Viral HPV DNA and Correlations With Disease Burden in Oropharyngeal Cancer
2025 · Jaclyn Lee, Ashtyn McAdoo, et al. · Otolaryngology · 4
PDF
Molecular imaging predicts trastuzumab‐deruxtecan (T‐ DX d) response in head and neck cancer xenograft models
2025 · Abdullah Bin Naveed, Lucas Mani, et al. · Molecular Oncology · 4
PDF
Use of Dual-Modality Antibody Imaging for Assessment of Lymph Node Metastases in Head and Neck Cancer
2026 · Nicole Meeks, Ashtyn G. McAdoo, et al. · Theranostics · 3
PDF
Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET / CT Scanner
2026 · Andreja Radevic, Joaquin Austerlitz, et al. · Head & Neck · 2
Efficacy of depatuxizumab mafodotin (ABT-414) in preclinical models of head and neck cancer
2024 · Lucas Mani, Abdullah Naveed, et al. · Carcinogenesis · 2
PDF
Early Feasibility of Registration of Micro‐ PET / CT Scans to Annotated 3D Specimen Models
2026 · Joaquin Austerlitz, Andreja Radevic, et al. · Head & Neck · 1
PDF
Automated cGMP optical labeling of FDA-approved antibodies for human use
2026 · Kamal Jouad, Marisa Hom, et al. · Nature Protocols · 1
Rapid Assessment of Target-Binding Fractions in Theranostic and Imaging Agents Using Size-Exclusion HPLC
2026 · Ashtyn McAdoo, Kamal Jouad, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Evaluation of Pafolacianine (Cytalux®) for Fluorescence-Guided Surgery in Head and Neck Squamous Cell Carcinoma: A Negative Study with Important Clinical Implications
2025 · Lucas Mani, Syeda Maria Ahmad Zaidi, et al. · Molecular Imaging and Biology · 1
PDF
Front Cover
2026 · Andreja Radevic, Joaquin Austerlitz, et al. · Head & Neck
PDF
Evaluating Suspected Tumor Recurrence with Epidermal Growth Factor Receptor–Targeted [ 89 Zr]Zr-Panitumumab PET/CT
2026 · Joseph Hoang, Kyrionna Golliday, et al. · Journal of Nuclear Medicine
Complete Pathologic Response to Neoadjuvant Pembrolizumab Captured on Intraoperative PET / CT : A Case Report and Exploratory Analysis
2026 · Joaquin Austerlitz, Andreja Radevic, et al. · Head & Neck
PDF
Response to: “Letter to Editor Following ‘Visualization of Scattered Tumor Regression Following Neoadjuvant Chemoimmunotherapy With a Novel Intraoperative PET / CT Scanner’”
2026 · Andreja Radevic, Joaquin Austerlitz, et al. · Head & Neck
Rapid assessment of target-binding fractions in molecular imaging agents using size-exclusion HPLC
2026 · Ashtyn McAdoo, Kamal Jouad, et al. · EJNMMI Radiopharmacy and Chemistry
Additional file 1 of Rapid assessment of target-binding fractions in molecular imaging agents using size-exclusion HPLC
2026 · Ashtyn McAdoo, Kamal Jouad, et al. · Figshare
Non‐ FDG ‐Avid Metastasis Detected by Molecular Imaging in Unknown Primary of the Head and Neck
2025 · Nicole Meeks, Ashtyn McAdoo, et al. · The Laryngoscope
PDF
FAP+ cells restrict antibody drug delivery and promote an immunosuppressive environment in head and neck squamous cell carcinoma.
2025 · Candace Grisham, Hidenori Tanaka, et al. · Research Square
Author response for "Molecular imaging predicts trastuzumab‐deruxtecan (T‐ DX d) response in head and neck cancer xenograft models"
2024 · Abdullah Bin Naveed, Lucas Mani, et al.
365 (PB353): Targeting fibroblast activation protein to improve immunotherapy efficacy in head and neck squamous cell carcinoma
2024 · C. Grisham, H. Tanaka, et al. · European Journal of Cancer
Works count: 20
Citation count: 31
H-index: 3
I10-index: 1
Year
Topic
Type